REGULATED PRESS RELEASE published on 10/21/2025 at 07:05, 1 year ago Edenred et Visa annoncent un partenariat stratégique pour accélérer l'innovation dans les domaines des avantages aux salariés, de la mobilité et des solutions de paiement B2B Edenred et Visa s'associent pour stimuler l'innovation dans les paiements B2B et avantages aux salariés. Renforcement des capacités technologiques et du réseau d'Edenred Edenred Innovation Partenariat Paiements B2B Visa
REGULATED PRESS RELEASE published on 10/21/2025 at 07:05, 1 year ago Edenred and Visa announce a strategic partnership to accelerate innovation across Benefits and Engagement, Mobility, and B2B Payment Solutions Edenred and Visa announce a strategic partnership to drive innovation and expand their reach in commercial and consumer payment ecosystems. The collaboration strengthens Edenred's platform through the certification of its in-house issuing and processing infrastructure with Visa Europe Edenred Innovation Payment Solutions Strategic Partnership Visa
PRESS RELEASE published on 10/21/2025 at 07:00, 1 year ago Sonova expands AI leadership with innovations debuting at EUHA 2025 Sonova Holding AG introduces Infinio Ultra Sphere and enhanced Infinio hearing aid range at EUHA 2025, focusing on speech clarity, extended battery life, and innovative wax management system Sonova Holding AG Hearing Aids Infinio Ultra Sphere Speech Clarity AI Chip
REGULATED PRESS RELEASE published on 10/21/2025 at 07:00, 1 year ago Edenred enregistre une croissance de son activité au troisième trimestre 2025 plus élevée qu’au premier semestre Edenred affiche une croissance de +8,2% de son chiffre d'affaires au 3ème trimestre 2025 par rapport à 2024. Objectifs confirmés pour 2025 malgré l'impact du changement réglementaire en Italie Edenred Chiffre D'affaires Croissance Objectifs 2025 Trimestre 2025
REGULATED PRESS RELEASE published on 10/21/2025 at 07:00, 1 year ago Edenred reports higher growth in its activity in the third quarter of 2025 compared to the first half of the year Edenred reports strong revenue growth in third-quarter 2025, with total revenue reaching €726 million, up 7.3% like-for-like. Operating revenue up 8.2%, driven by growth across all business lines and regions Edenred Revenue Growth Business Lines Operating Revenue Q3 2025
REGULATED PRESS RELEASE published on 10/21/2025 at 07:00, 1 year ago Chiffre d'affaires 9 mois 2025. 710 M€ à devises constantes (+4,4 %) Interparfums annonce un chiffre d'affaires en hausse de 4,4 % sur 9 mois malgré la faiblesse du dollar. Les parfums Jimmy Choo et Coach affichent des croissances notables Chiffre D'affaires Croissance Interparfums Parfums Jimmy Choo
REGULATED PRESS RELEASE published on 10/21/2025 at 07:00, 1 year ago 2025 nine-month sales. €710m at constant exchange rates (+4.4%) Interparfums reports €710m sales in first nine months of 2025, up 4.4% at constant exchange rates. Strong performance in flagship brands with Jimmy Choo fragrances driving growth Sales Interparfums Growth Fragrances 2025
PRESS RELEASE published on 10/21/2025 at 06:45, 1 year ago HUBER+SUHNER achieves significantly higher order intake in the first nine months of 2025 HUBER+SUHNER achieves significantly higher order intake in the first nine months of 2025, with Communication segment leading the growth. Net sales reach prior-year level Net Sales Order Intake HUBER+SUHNER Industry Segment Communication Segment
PRESS RELEASE published on 10/21/2025 at 06:32, 1 year ago Q3 2025: Solid Group revenue Q3 2025: Solid Group revenue with Eurotunnel revenue up 3%. Eleclink revenue down 13%. Europorte revenue up 5%. CEO confirms EBITDA target Group Revenue ElecLink EBITDA Target Eurotunnel Q3 2025
PRESS RELEASE published on 10/21/2025 at 06:30, 1 year ago Formycon’s FYB201/Ranivisio® sets innovative standard as Europe’s First Ranibizumab Biosimilar available in Pre-filled Syringe Formycon's FYB201/Ranivisio® is Europe's First Ranibizumab Biosimilar available in Pre-filled Syringe, offering improved handling, accuracy, and convenience for applicants. Teva to commercialize across Europe Europe Biosimilar Formycon Teva Ranivisio
Published on 11/06/2026 at 05:15, 4 hours 39 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 00:53, 9 hours 1 minute ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 9 hours 9 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 9 hours 59 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/06/2026 at 09:42, 11 minutes ago Silver for the Thorium Pioneer: Emerald Horizon Takes Second Place at “Innovator of the Year” 2026
Published on 11/06/2026 at 09:10, 44 minutes ago Rentschler Biopharma Receives the Business Medal of the State of Baden-Wuerttemberg
Published on 11/06/2026 at 09:04, 49 minutes ago PARMANTIER & CIE. appoints Stefan Heieck and Harry Tyser as Senior Advisors
Published on 11/06/2026 at 09:00, 54 minutes ago Nexum Group Listing – Trading on the Frankfurt Stock Exchange's Regulated Market has begun
Published on 11/06/2026 at 09:07, 47 minutes ago Mise à disposition de la note d'information de M14 dans le cadre de l'OPR visant les actions BOURRELIER GROUP
Published on 11/06/2026 at 09:04, 49 minutes ago Mise à disposition de la note d'information en réponse établie par BOURRELIER GROUP initiée par M14
Published on 11/05/2026 at 18:21, 15 hours 32 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 15 hours 32 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026